The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US8975267, 16 ID: ALA3703188
Chembl Id: CHEMBL3703188
PubChem CID: 60141693
Max Phase: Preclinical
Molecular Formula: C35H43N7O2
Molecular Weight: 593.78
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCc1cccc(CC)c1NC(=O)c1cn(C)c2c1CCCc1cnc(Nc3ccc(N4CCN(C)CC4)cc3OC)nc1-2
Standard InChI: InChI=1S/C35H43N7O2/c1-6-23-10-8-11-24(7-2)31(23)38-34(43)28-22-41(4)33-27(28)13-9-12-25-21-36-35(39-32(25)33)37-29-15-14-26(20-30(29)44-5)42-18-16-40(3)17-19-42/h8,10-11,14-15,20-22H,6-7,9,12-13,16-19H2,1-5H3,(H,38,43)(H,36,37,39)
Standard InChI Key: CNSGSATYYDDERW-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 593.78Molecular Weight (Monoisotopic): 593.3478AlogP: 5.85#Rotatable Bonds: 8Polar Surface Area: 87.55Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 7.85CX LogP: 7.24CX LogD: 6.66Aromatic Rings: 4Heavy Atoms: 44QED Weighted: 0.26Np Likeness Score: -1.23
References 1. (2015) Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors,